Globus Medical (GMED) Reports In-Line Q2 EPS

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $263.6 million versus the consensus estimate of $259.38 million.

GUIDANCE:

Globus Medical sees FY2022 EPS of $2.10, versus the consensus of $2.09. Globus Medical sees FY2022 revenue of $1.025 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Barnes Group (B) Tops Q1 EPS by 2c; Raises guidance
• Airbus revenue rises, delivers 142 commercial aircraft in Q1